BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33217796)

  • 1. Systemic treatment of a metastatic carotid body tumor: A case report and literature review.
    Xing J; Cheng Y; Ying H; Guan M; Jia N; Bai C
    Medicine (Baltimore); 2020 Nov; 99(47):e22811. PubMed ID: 33217796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET scan assessment of chemotherapy response in metastatic paraganglioma.
    Argiris A; Mellott A; Spies S
    Am J Clin Oncol; 2003 Dec; 26(6):563-6. PubMed ID: 14663372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma.
    He J; Makey D; Fojo T; Adams KT; Havekes B; Eisenhofer G; Sullivan P; Lai EW; Pacak K
    Endocrine; 2009 Oct; 36(2):189-93. PubMed ID: 19618298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
    Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
    Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid body paraganglioma metastatic to spine causing cord compression: a case report.
    Tabb JN; Maas JA; Earla BP; Fallon KB; McDonald AM; Dobelbower MC
    Diagn Pathol; 2023 Feb; 18(1):31. PubMed ID: 36829189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of patients with carotid body tumor with cervical lymph node metastasis: A retrospective study of 10 cases and review of the literature.
    Yang L; Li W; Zhang H; Yu L; Zheng M
    Medicine (Baltimore); 2022 Sep; 101(36):e30379. PubMed ID: 36086729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
    Asai S; Katabami T; Tsuiki M; Tanaka Y; Naruse M
    Horm Cancer; 2017 Apr; 8(2):108-118. PubMed ID: 28108930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].
    Naoi Y; Tamaki Y; Ooka M; Tsukamoto F; Miyoshi Y; Tanji Y; Taguchi T; Noguchi S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):145-9. PubMed ID: 12557721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
    Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
    Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
    Nikolova PN; Hadzhiyska VH; Mladenov KB; Ilcheva MG; Veneva S; Grudeva VV; Dineva SE; Asenov YN
    Neoplasma; 2021 Jan; 68(1):180-189. PubMed ID: 32880466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.
    Wang L; Dong P; Hu W; Tian B
    Medicine (Baltimore); 2020 Jan; 99(5):e18980. PubMed ID: 32000430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of metastatic paratesticular rhabdomyosarcoma in an adult successfully treated with multidrug combination chemotherapy].
    Kobayashi S; Tsukamoto T; Tohma T
    Hinyokika Kiyo; 2010 Sep; 56(9):531-3. PubMed ID: 20940531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Kollberg P; Almquist H; Bläckberg M; Cwikiel M; Gudjonsson S; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2017 Aug; 51(4):308-313. PubMed ID: 28532260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
    Dose Schwarz J; Bader M; Jenicke L; Hemminger G; Jänicke F; Avril N
    J Nucl Med; 2005 Jul; 46(7):1144-50. PubMed ID: 16000283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.